Synthesis and cytotoxic activity of two novel 1-dodecylthio-2-decyloxypropyl-3-phosphatidic acid conjugates with gemcitabine and cytosine arabinoside

被引:33
作者
Alexander, RL
Morris-Natschke, SL
Ishaq, KS
Fleming, RA
Kucera, GL
机构
[1] Wake Forest Univ, Sch Med, Dept Internal Med, Hematol Oncol Sect, Winston Salem, NC 27517 USA
[2] Wake Forest Univ, Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27517 USA
[3] Univ N Carolina, Sch Pharm, Dept Med Chem & Nat Prod, Chapel Hill, NC 27599 USA
[4] Kucera Pharmaceut Co, Winston Salem, NC 27101 USA
关键词
D O I
10.1021/jm020571x
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cytosine arabinoside (ara-C) and gemcitabine (dFdC) are two standard chemotherapy drugs used in the treatment of patients with various cancers. To alter the pharmacokinetic and pharmacodynamic properties of these molecules, we conjugated a synthetic phospholipid to both ara-C and dFdC and investigated their chemotherapeutic potential. The dFdC conjugate had greater cytotoxic activity compared with the ara-C conjugate and demonstrated notable cytotoxicity against all human cell lines tested.
引用
收藏
页码:4205 / 4208
页数:4
相关论文
共 19 条
[1]   KINETIC-STUDIES ON 2',2'-DIFLUORODEOXYCYTIDINE (GEMCITABINE) WITH PURIFIED HUMAN DEOXYCYTIDINE KINASE AND CYTIDINE DEAMINASE [J].
BOUFFARD, DY ;
LALIBERTE, J ;
MOMPARLER, RL .
BIOCHEMICAL PHARMACOLOGY, 1993, 45 (09) :1857-1861
[2]   Synthesis and antiproliferative potency of 9-β-D-arabinofuranosyl-2-fluoroadenine phospholipid adducts [J].
Brachwitz, H ;
Bergmann, J ;
Thomas, Y ;
Wollny, T ;
Langen, P .
BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (06) :1195-1200
[3]   PHASE-II TRIAL OF GEMCITABINE (2,2'-DIFLUORODEOXYCYTIDINE) IN PATIENTS WITH ADENOCARCINOMA OF THE PANCREAS [J].
CASPER, ES ;
GREEN, MR ;
KELSEN, DP ;
HEELAN, RT ;
BROWN, TD ;
FLOMBAUM, CD ;
TROCHANOWSKI, B ;
TARASSOFF, PG .
INVESTIGATIONAL NEW DRUGS, 1994, 12 (01) :29-34
[4]  
CHABNER BA, 1989, CANCER PRINCIPLES PR, P349
[5]  
FRAM RJ, 1982, CANCER RES, V42, P4050
[6]   GEMCITABINE IN LEUKEMIA - A PHASE-I CLINICAL, PLASMA, AND CELLULAR PHARMACOLOGY STUDY [J].
GRUNEWALD, R ;
KANTARJIAN, H ;
DU, M ;
FAUCHER, K ;
TARASSOFF, P ;
PLUNKETT, W .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (03) :406-413
[7]  
Herrmann D. B. J., 1997, Naunyn-Schmiedeberg's Archives of Pharmacology, V356, pR44
[8]   NUCLEOSIDE CONJUGATES .13. SYNTHESIS AND ANTITUMOR-ACTIVITY OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE CONJUGATES OF THIOETHER LIPIDS WITH IMPROVED WATER SOLUBILITY [J].
HONG, CI ;
NECHAEV, A ;
KIRISITS, AJ ;
VIG, R ;
WEST, CR .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (12) :1785-1790
[9]  
HUANG P, 1995, SEMIN ONCOL, V22, P19
[10]   TRANSPORT AND PHOSPHORYLATION AS FACTORS IN ANTITUMOR ACTION OF CYTOSINE ARABINOSIDE [J].
KESSEL, D ;
HALL, TC .
SCIENCE, 1967, 156 (3779) :1240-+